1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

Cell Therapeutics, Inc. under investigation over possible securities laws violations

Investigation on behalf of investors of Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) over possible violations of securities laws by Cell Therapeutic – Contact the Shareholders Foundation, Inc

FOR IMMEDIATE RELEASE

 
mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
PRLog (Press Release) - Mar 12, 2010 -
An investigation on behalf of investors in Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) concerning shareholder claims over potential violations of Federal Securities Laws by Cell Therapeutics and others was announced.

If you are a current long term investor in Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) stock, you have certain options and you should contact the Shareholders Foundation, Inc by email: mail@shareholdersfoundation.com or call +1 (858) 779 – 1554.

According to the investigation by a law firm the investigation on behalf of CTIC shareholders focuses on “whether a series of statements regarding Cell Therapeutics’ business, its prospects and its operations were materially false and misleading at the time they were made.”

Cell Therapeutics, Inc., located in Seattle, WA, develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs. Its research, development, acquisition and in-licensing activities concentrate on identifying and developing less toxic ways to treat cancer.

Cell Therapeutics, Inc. shares (CTIC) split in 2008 and traded recently at $0.997 per share, down from its 52weekHigh of $2.23 per share. CTIC reached an unbelievable $2940 per share during the dotcom bubble in 2000, and continued to fall to approximately $1000 per share in 2001 with an additional substantial decline in 2002 from $1000 to $300 per share. Since 2002 CTIC has lost ground a traded before the financial crisis in 2008 under $5 per share.

Those who are current long term investors in Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) stock, have certain options and should contact the Shareholders Foundation, Inc by email: mail@shareholdersfoundation.com or call +1 (858) 779 – 1554.

# # #

The Shareholders Foundation, Inc. is an investor advocacy group. We do research related to shareholder issues and inform investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. At Shareholders Foundation, Inc. we are in contact with a large number of shareholders. We believe that together we can combine the interests of many investors, and use the size of our interest as leverage against the giant corporations. We offer help, support, and assistance for every shareholder. We help investors find answers to their questions and equitable solutions to their problems. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

--- end ---

Click to Share

Contact Email:
***@shareholdersfoundation.com Email Verified
Issued By:Shareholders Foundation, Inc.
Phone:+1-(858)-779-1554
Fax:+1-(858)-605-5739
Address:3111 Camino Del Rio North - Suite 423 –
Zip:92108
City/Town:San Diego
State/Province:California
Country:United States
Industry:Banking, Business, Finance
Tags:, ,
Last Updated:Mar 11, 2010
Shortcut:http://prlog.org/10571542
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share